Log in to your Inderes Free account to see all free content on this page.
PExA
0.27 SEK
Less than 1K followers
PEXA B
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+2.26 %
+40.93 %
+14.29 %
+49.65 %
+69.75 %
+21.42 %
-44.72 %
-80.85 %
-86.99 %
PExA offers a patented, non-invasive technology to collect biomarkers from the small airways of the lung via exhaled air. The method is used globally by universities, hospitals, pharmaceutical companies, CROs and government agencies in the US and Europe, among others – in research on asthma, COPD, lung cancer, occupational exposure and pharmacokinetics. The company's goal is to enable earlier diagnosis and screening of lung diseases. PExA was founded in 2014 and is headquartered in Gothenburg.
Read moreMarket cap
33.76M SEK
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
19.2.
2026
Annual report '25